down arrow

Vijaya Diagnost.

  • Market Cap: Mid Cap
  • Industry: Hospital & Healthcare Services
  • ISIN: INE043W01024
  • NSEID: VIJAYA
  • BSEID: 543350
INR
956.85
-23.15 (-2.36%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 5.25 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

5.25 lacs (-61.66%) Volume

Shareholding (Dec 2024)

FII

17.54%

Held by 128 FIIs

DII

24.63%

Held by 30 DIIs

Promoter

53.91%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

High Management Efficiency with a high ROE of 17.92%

 
2

Company has a low Debt to Equity ratio (avg) at 0 times

 
3

Poor long term growth as Net Sales has grown by an annual rate of 13.13% and Operating profit at 7.54% over the last 5 years

 
4

The company has declared Positive results for the last 6 consecutive quarters

5

Stock is technically in a Mildly Bullish range

6

With ROCE of 23.4, it has a Very Expensive valuation with a 12.6 Enterprise value to Capital Employed

7

High Institutional Holdings at 42.17%

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Hospital & Healthcare Services

stock-summary
Market cap

INR 9,821 Cr (Mid Cap)

stock-summary
P/E

71.00

stock-summary
Industry P/E

55

stock-summary
Dividend Yield

0.10%

stock-summary
Debt Equity

0.11

stock-summary
Return on Equity

18.50%

stock-summary
Price to Book

13.88

Revenue and Profits (1 Year):
Net Sales:
169 Cr
(Quarterly Results - Dec 2024)
Net Profit:
35 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.1%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-2.96%
0%
-2.96%
1 Year
42.86%
0.15%
43.01%
2 Years
143.01%
0.54%
143.55%
3 Years
110.9%
0.81%
111.71%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Latest dividend: 1 per share ex-dividend date: Aug-30-2024

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
13.13%
EBIT Growth (5y)
7.54%
EBIT to Interest (avg)
7.62
Debt to EBITDA (avg)
1.13
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.64
Tax Ratio
24.81%
Dividend Payout Ratio
8.61%
Pledged Shares
0
Institutional Holding
42.17%
ROCE (avg)
28.64%
ROE (avg)
17.92%
Valuation key factors
Factor
Value
P/E Ratio
71
Industry P/E
55
Price to Book Value
13.88
EV to EBIT
50.85
EV to EBITDA
37.91
EV to Capital Employed
12.59
EV to Sales
15.28
PEG Ratio
3.00
Dividend Yield
0.10%
ROCE (Latest)
23.39%
ROE (Latest)
18.50%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 21 Schemes (23.97%)

FIIs

Held by 128 FIIs (17.54%)

Promoter with highest holding

Surendranath Reddy Sura (32.57%)

Highest Public shareholder

Nippon Life India Trustee Ltd-a/c Nippon India Mul (5.63%)

Individual Investors Holdings

3.43%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -7.64% vs 17.11% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -16.17% vs 33.78% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "168.98",
          "val2": "182.95",
          "chgp": "-7.64%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "67.12",
          "val2": "75.99",
          "chgp": "-11.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "6.82",
          "val2": "6.47",
          "chgp": "5.41%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "35.16",
          "val2": "41.94",
          "chgp": "-16.17%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "39.72%",
          "val2": "41.54%",
          "chgp": "-1.82%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 30.50% vs 15.46% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 23.10% vs 45.98% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "339.17",
          "val2": "259.91",
          "chgp": "30.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "137.22",
          "val2": "105.49",
          "chgp": "30.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "12.73",
          "val2": "11.74",
          "chgp": "8.43%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "73.28",
          "val2": "59.53",
          "chgp": "23.10%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "40.46%",
          "val2": "40.59%",
          "chgp": "-0.13%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 29.43% vs 16.07% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 27.01% vs 49.42% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "508.15",
          "val2": "392.60",
          "chgp": "29.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "204.34",
          "val2": "157.79",
          "chgp": "29.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "19.55",
          "val2": "17.80",
          "chgp": "9.83%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-2.05",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "108.44",
          "val2": "85.38",
          "chgp": "27.01%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "40.21%",
          "val2": "40.19%",
          "chgp": "0.02%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 19.29% vs -0.68% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 40.41% vs -22.84% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "547.81",
          "val2": "459.22",
          "chgp": "19.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "220.91",
          "val2": "182.02",
          "chgp": "21.37%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "23.99",
          "val2": "20.95",
          "chgp": "14.51%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-2.05",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "118.83",
          "val2": "84.63",
          "chgp": "40.41%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "40.33%",
          "val2": "39.64%",
          "chgp": "0.69%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
168.98
182.95
-7.64%
Operating Profit (PBDIT) excl Other Income
67.12
75.99
-11.67%
Interest
6.82
6.47
5.41%
Exceptional Items
0.00
0.00
Consolidate Net Profit
35.16
41.94
-16.17%
Operating Profit Margin (Excl OI)
39.72%
41.54%
-1.82%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is -7.64% vs 17.11% in Sep 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2024 is -16.17% vs 33.78% in Sep 2024

Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
339.17
259.91
30.50%
Operating Profit (PBDIT) excl Other Income
137.22
105.49
30.08%
Interest
12.73
11.74
8.43%
Exceptional Items
0.00
0.00
Consolidate Net Profit
73.28
59.53
23.10%
Operating Profit Margin (Excl OI)
40.46%
40.59%
-0.13%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 30.50% vs 15.46% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is 23.10% vs 45.98% in Sep 2023

Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
508.15
392.60
29.43%
Operating Profit (PBDIT) excl Other Income
204.34
157.79
29.50%
Interest
19.55
17.80
9.83%
Exceptional Items
0.00
-2.05
100.00%
Consolidate Net Profit
108.44
85.38
27.01%
Operating Profit Margin (Excl OI)
40.21%
40.19%
0.02%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 29.43% vs 16.07% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is 27.01% vs 49.42% in Dec 2023

Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
547.81
459.22
19.29%
Operating Profit (PBDIT) excl Other Income
220.91
182.02
21.37%
Interest
23.99
20.95
14.51%
Exceptional Items
-2.05
0.00
Consolidate Net Profit
118.83
84.63
40.41%
Operating Profit Margin (Excl OI)
40.33%
39.64%
0.69%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 19.29% vs -0.68% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is 40.41% vs -22.84% in Mar 2023

stock-summaryCompany CV
About Vijaya Diagnostic Centre Ltd stock-summary
stock-summary
Vijaya Diagnostic Centre Ltd
Mid Cap
Hospital & Healthcare Services
Vijaya Diagnostic Centre Limited established in 1981, is a leading provider of diagnostic services in India. With a steadfast commitment to delivering high quality, comprehensive diagnostic solutions, Vijaya has grown into the largest integrated diagnostic chain in Southern India. Founded by Dr. S. Surendranath Reddy, the journey began to offer reliable and comprehensive diagnostic services under one roof.
Company Coordinates stock-summary
Icon
No Company Details Available